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Endotoxemia can cause profound myocardial dysfunction
contributing to hypotension and shock. Overproduction
of nitric oxide (NO) has been implicated as a cause of the
myocardial dysfunction of sepsis. Here, we tested the
hypothesis that myocyte-specific overexpression of NO
synthase 3 (NOS3) can prevent cardiac dysfunction in
endotoxin-challenged mice.
Echocardiographic measurements were obtained before
and 4 and 7 h after intraperitoneal challenge with endo-
toxin (Escherichia coli 0111:B4 lipopolysaccaride 50 mg/
kg) in wild-type C57BL6 mice (WT) and WT mice with
myocyte-specific overexpression of NOS3 (TG), using a
13-MHz ultrasound probe (Sequoia, Acuson, Mountain
View, CA). Invasive measurements of LV pressure and vol-
ume were obtained with a 1.4F pressure-volume catheter
(SPR-839, Millar Instruments, Houston TX) (7 h after
challenge with endotoxin or saline).
At baseline, WT and TG mice had comparable measures of
LV function. However, as assessed by echocardiography,
the endotoxin-induced decrease in LV fractional shorten-
ing was attenuated in TG mice (from 54 ± 1 to 40 ± 1%)
as compared to WT mice (from 56 ± 1 to 31 ± 2%). Inva-
sive hemodynamics revealed that, compared to saline-
challenged mice, dP/dtmax and cardiac output (CO) were
markedly impaired in WT but not in TG 7 h after endo-
toxin challenge (Table 1).
Myocyte-specific overexpression of NOS3 prevented
endotoxin-induced reduction of minimally load-inde-
pendent measures of LV function, including maximal
power divided by end-diastolic volume (PMXEDV), dP/
dtmax divided by instantaneous pressure (dP/dtmax/IP) and
LV end-systolic elastance (Ees).
These results suggest that myocyte-specific overexpression
of NOS3 confers protection against endotoxin-induced
myocardial dysfunction.
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Table 1: Cardiac function at baseline and 7 h after endotoxin-challenge in WT and TG mice
dP/dtmax (mmHg/s) CO (mL/min) PMXEDV (mmHg/s) dP/dtmax/IP (s-1) Ees (mmHg/µL)
WT baseline 15124 ± 1087 14.5 ± 1.9 50 ± 3 287 ± 12 11 ± 2
7h endotoxin 10024 ± 609* 6.1 ± 0.9* 31 ± 5* 161 ± 18* 3 ± 1*
TG baseline 14562 ± 1491 15.6 ± 2.7 43 ± 2 255 ± 16 11 ± 4
7h endotoxin 15354 ± 495# 15.7 ± 0.7# 52 ± 5 228 ± 9 12 ± 2#
*P < 0.05 vs baseline, #P < 0.05 vs WT
